0.052
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Market Closed
Best deals to access real time data! |
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
Small Cap Pro
Monthly Subscription
for only
|
Canna Trader Pro
Monthly Subscription
for only
|
VAT not included
|
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Grey Cloak Tech Inc (QB) | GRCK | OTCMarkets | Common Stock |
Price Change | Change Percent | Stock Price | Last Traded ![]() |
|
---|---|---|---|---|
0.00 | 0.0% | 0.052 | 20:00:00 |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.052 | 0.052 |
Bid Price | Ask Price | Spread | News | |
---|---|---|---|---|
0.0512 | 0.069 | 0.0178 | - | - |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
- | 0 | $ 0.052 | USD |
Grey Cloak Tech (QB) Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
$ 16.30M | 317.30M | 128.91M | $ - | $ - | - | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
97.00 | $ - | 0.00% | - | - |
Grey Cloak Tech (QB) News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical GRCK Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.0% |
1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.0% |
3 Months | 0.0685 | 0.09 | 0.0401 | 0.0579591 | 47,756 | -0.0165 | -24.09% |
6 Months | 0.061 | 0.11 | 0.0401 | 0.0649596 | 35,401 | -0.009 | -14.75% |
1 Year | 0.05 | 0.11 | 0.03 | 0.0649296 | 30,368 | 0.002 | 4.0% |
3 Years | 0.0004 | 0.25 | 0.0003 | 0.003448 | 738,480 | 0.0516 | 12,900.0% |
5 Years | 0.38 | 0.605 | 0.0003 | 0.006616 | 2,318,642 | -0.328 | -86.32% |
Grey Cloak Tech (QB) Description
Healthy Extracts Inc., through its growing portfolio of wholly owned subsidiaries, is engaged in the proprietary research and development of natural plant-based formulations, sales, and distribution of proprietary clinically proven cardiovascular and neuro products. The company's focus is to advance its market positions in the broader health industry through the unique assets and operations of its science-based BergaMet North America and Ultimate Brain Nutrients ("UBN") subsidiaries and to offer better lifestyles through superior health technology. |